ImmunityBio

ImmunityBio is a biotech firm focused on developing innovative cell and immunotherapy products aimed at enhancing the natural immune system to combat diseases, including cancer. The company’s mission is to empower the immune system to outsmart and eliminate cancerous or infected cells. ImmunityBio is committed to increasing diversity in clinical trials to ensure that results help reduce healthcare disparities. Founded by Dr. Patrick Soon-Shiong, the company is dedicated to pioneering new frontiers in immunotherapy.

ImmunityBio has achieved significant milestones, including collaborations with the Serum Institute of India to manufacture BCG at a large scale and advancements in treatments for non-muscle invasive bladder cancer. Dr. Patrick Soon-Shiong, a notable figure in biotechnology, leads the company. ImmunityBio's efforts in diversifying clinical trial participation and its innovative approaches have positioned it as a key player in the biotech industry, striving to make impactful changes in healthcare.